Clinical Trials on Human Health

Total 94770 results

Prothya Biosolutions

Completed

Intravenous Immunoglobulin (IVIg) for Parvovirus B19(PVB19) Mediated Cardiomyopathy

Myocardial Diseases | Parvovirus B19, Human

Netherlands
GlaxoSmithKline
Shionogi

Completed

GSK1349572 Drug Interaction Study With Protease Inhibitors

Healthy Subjects | Infection, Human Immunodeficiency Virus

United States
GlaxoSmithKline

Completed

Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs

Healthy Subjects | Infection, Human Immunodeficiency Virus

United States
Hannover Medical School

Recruiting

Monitoring of Donor-specific Antibodies After Treatment With Immunoglobulins, Plasmapheresis and Rituximab in Lung Transplantation

Lung Transplantation | Donor-specific Anti-human Leukocyte Antigen(HLA) Antibodies

Germany
Cairo University

Unknown

Propylene Mesh VS Standard Customized Palatal Stent as Protective Mechanical Barrier

Randomized Controlled Trial, Human Study

Egypt
The Alfred
Merck Sharp & Dohme LLC

Completed

Human Papillomavirus (HPV) Infection in Young Men Who Have Sex With Men (HYPER)

Human Papillomavirus

Australia
University of Florida
Merck Sharp & Dohme LLC

Completed

Prevalence, Persistence, and Risk Factors for Oral Human Papillomavirus (HPV) Infections in College Women (HOP-IN)

Human Papillomavirus

United States
IRCCS Centro Neurolesi "Bonino-Pulejo"

Completed

Promoting Mental and Physical Well-being Through Smart Health

Health Behavior | Healthy Lifestyle

Italy
Baylor Research Institute
Discovery Foundation

Terminated

The Reproductive Microbiome & Perinatal Health Outcomes

PreTerm Birth | Metabolomics | Human Microbiota | Human Gastrointestinal Microbiota
Merck Sharp & Dohme LLC

Withdrawn

MK-8510 Monotherapy for the Treatment of Anti-retroviral naïve Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8510-002)

HIV-1 | Immunodeficiency Virus Type 1, Human | Human Immunodeficiency Virus Type 1 | Human Immunodeficiency Virus 1
Sanofi Pasteur, a Sanofi Company

Completed

Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and Older

Influenza | Healthy Volunteers

United States
Solvay Pharmaceuticals

Withdrawn

Annual Study to Investigate Inactivated Virosomal Influenza Vaccine for the 2006/2007 Influenza Season in Europe.

Healthy Volunteers

Germany
Solvay Pharmaceuticals

Completed

Annual Study to Investigate Influenza Vaccine Due to New Virus Strains for the 2007/2008 Influenza Season in Europe

Healthy Volunteers

Belgium, Germany
Seqirus

Completed

Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults

Influenza | Human

United States
Agrupamento de Centros de Saúde de Dão Lafões

Completed

Factors Influencing Flu Vaccination in Primary Health Care (FIVA)

Flu, Human

Portugal
Advagene Biopharma Co. Ltd.
National Taiwan University Hospital

Completed

Study of the Safety, Tolerability and Immunogenicity of an Intranasal Influenza Vaccine Administered to Healthy Adults

Flu, Human

Taiwan
Protein Sciences Corporation
Kaiser Permanente

Completed

Post-Marketing Observational Study of Safety Following Vaccination With Flublok® Compared to Licensed IIV in Adults

Human Influenza

United States
Novartis Vaccines

Completed

Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults Aged 18 Years and Above

Influenza | Human

Germany
University of North Carolina, Chapel Hill
Robert Wood Johnson Foundation

Not yet recruiting

Impacts of Warning Labels on Ultra-Processed Foods

Health Behavior | Diet, Healthy

United States
Icahn School of Medicine at Mount Sinai
Sesame Workshop

Enrolling by invitation

Children's Lifestyle, Diet, and Exercise Intervention - CHILDREN's Project

Healthy Lifestyle | Cardiovascular Health

United States
Ankara Medipol University

Completed

Investigation of the Effects of Pilates Training in Pregnant Women

Health Behavior | Healthy Lifestyle

Turkey
Brigham and Women's Hospital
Linnaeus University

Active, not recruiting

Successful Aging and Enrichment (SAGE) (SAGE)

Healthy Aging | Cognitive Health

United States
Mbarara University of Science and Technology

Completed

Using a Mobile Phone-based Multimedia Technology to Support Maternal Health in Rural Southwestern Uganda (MatHealth)

mHealth | Maternal Health | Multimedia

Uganda
Huazhong University of Science and Technology

Recruiting

Study of Targeted Therapy Using Transcription Activator-like Effector Nucleases in Cervical Precancerous Lesions

Human Papillomavirus-Related Malignant Neoplasm

China
Robotrak Technologies Co., Ltd.

Completed

Clinical Research Plan for Human Myopia Models

Human Myopia Model

China
Huazhong University of Science and Technology

Unknown

Study of Molecular-targeted Therapy Using Zinc Finger Nuclease in Cervical Precancerous Lesions

Human Papillomavirus-Related Malignant Neoplasm

China
Assistance Publique - Hôpitaux de Paris

Completed

Study of Analgesics Drug and Human Milk Transfer in Mature Milk, to Avoid Breastfeeding Cessation Without Scientific Probes (ANTALAIT)

Analgesics Use During Breastfeeding and Concentrations in Human Mature Milk

France
Kyorin University

Completed

MicroRNA Expression Profile in Human Vitreous of Patients With Various Vitreoretinal Diseases Requiring Vitrectomy

MicroRNA Expression Profile in Human Vitreous of Various Vitreoretinal Diseases

Japan
Fluart Innovative Vaccine Ltd, Hungary

Completed

Safety of 4Fluart ID Suspension for Injection in Adult Subjects

Human Influenza

Hungary
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines

Influenza | Healthy Volunteers

United States
University of Maryland, Baltimore
D'Antonio Consultants International, Inc.

Completed

Safety Study of Seasonal Influenza Vaccine by Jet Injection

Healthy Adults

United States
St. Jude Children's Research Hospital

Completed

Influenza Virus Vaccine Plus Vitamin A and D Supplements for Prevention of Respiratory Virus Infections in Children

Healthy Participants

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Withdrawn

Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants

Human Papillomavirus Infection | Healthy Subject

United States
Massachusetts General Hospital

Completed

Safety of Lactobacillus Rhamnosus GG Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine

Healthy | Elderly

United States
MassBiologics

Completed

Study in Healthy Volunteers to Evaluate a Human Monoclonal Antibody Against Hepatitis C (MBL-HCV1)

Healthy

United States
PT Bio Farma

Completed

The Safety and Immunogenicity of DTP/Hepatitis B 10ug Hib Vaccine (Bio Farma)

Healthy

Indonesia
University of Florida
Danstar Ferment AG

Active, not recruiting

Beta-glucan and Immune Response to Influenza Vaccine (M-Unity)

Healthy Aging

United States
CHA Vaccine Institute Co., Ltd.

Completed

A Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of the Third Generation Hepatitis B Vaccine

Healthy
Bristol-Myers Squibb

Completed

A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)

Healthy | Hepatitis C

United States, Puerto Rico
National Centre for Epidemiology, Hungary
Netherlands Vaccine Institute; National Public Health Institute, Finland

Unknown

Comparison of the Cellular and the Humoral Immunogenicity, Safety of Different Trivalent Influenza Vaccines (FLUSECUOEKH1)

Healthy Volunteers

Hungary
Solvay Pharmaceuticals

Completed

Annual Study to Investigate Inactivated Subunit Influenza Vaccine for the 2006/2007 Influenza Season in Europe.

Healthy Volunteers

Belgium
Immutep S.A.S.
SGS Aster-Cephac (CRO)

Completed

A Randomized Phase I Study of a Hepatitis B Antigen Combined With IMP321

Healthy

France
ModernaTX, Inc.

Active, not recruiting

Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure

Human Metapneumovirus and Human Parainfluenza Infection

United States
National Bureau of Economic Research, Inc.
National Institute on Aging (NIA)

Completed

The Effect of Proximity on Flu-Shot Participation

Influenza | Human

United States
Harvard University
National Institute on Aging (NIA); Massachusetts Institute of Technology; Ludwig-Maximilians...

Completed

Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects

Covid19 | Influenza, Human | Flu, Human

United States
Fluart Innovative Vaccine Ltd, Hungary

Completed

Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents

Human Influenza
Research Institute for Biological Safety Problems
Research Institute of Influenza, Russia; Asfendiyarov Kazakh National Medical...

Completed

Preventive Effectiveness, Safety and Immunogenicity of a Allantoic Split Inactivated Seasonal Influenza Vaccine

Human Influenza

Kazakhstan
Novartis Vaccines

Completed

Safety and Immunogenicity of a Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above

Human Influenza

Belgium
Novartis Vaccines

Completed

Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, in Healthy Adults Aged 18 Years and Above

Human Influenza

Belgium
New York University
Université Montpellier; Hai Phong Medical University; Centre for Supporting Community...

Completed

DRug Use and Infections in Hai Phong ViEtnam Among Persons Who Inject Drugs (DRIVE)

Hepatitis C | HIV | Mental Health

Vietnam

Clinical Trials on Human Health

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations